Cellebrite DI (CLBT) Non-Current Deffered Revenue: 2020-2024

Historic Non-Current Deffered Revenue for Cellebrite DI (CLBT) over the last 5 years, with Dec 2024 value amounting to $45.2 million.

  • Cellebrite DI's Non-Current Deffered Revenue rose 15.96% to $239.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $239.7 million, marking a year-over-year increase of 15.96%. This contributed to the annual value of $45.2 million for FY2024, which is 3.93% down from last year.
  • Per Cellebrite DI's latest filing, its Non-Current Deffered Revenue stood at $45.2 million for FY2024, which was down 3.93% from $47.1 million recorded in FY2023.
  • Cellebrite DI's Non-Current Deffered Revenue's 5-year high stood at $47.1 million during FY2023, with a 5-year trough of $33.4 million in FY2020.
  • In the last 3 years, Cellebrite DI's Non-Current Deffered Revenue had a median value of $45.2 million in 2024 and averaged $44.8 million.
  • As far as peak fluctuations go, Cellebrite DI's Non-Current Deffered Revenue increased by 15.78% in 2022, and later fell by 3.93% in 2024.
  • Over the past 5 years, Cellebrite DI's Non-Current Deffered Revenue (Yearly) stood at $33.4 million in 2020, then grew by 8.93% to $36.4 million in 2021, then grew by 15.78% to $42.2 million in 2022, then rose by 11.68% to $47.1 million in 2023, then dropped by 3.93% to $45.2 million in 2024.